Trial Profile
A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Brilanestrant (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors Genentech
- 22 Jun 2016 New trial record